Search clinical trials for: Darifenacin,Overactive Bladder,antimuscarinic,M3 muscarinic receptor antagonist

Total 44948 results

Novartis
Procter and Gamble

Completed

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

Overactive Bladder (OAB)

United States
National Taiwan University Hospital

Completed

Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome

Antimuscarinic Drug

Taiwan
Buddhist Tzu Chi General Hospital

Completed

Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome

Overactive Bladder

Taiwan
University of Alabama at Birmingham
Allergan

Completed

Bladder Antimuscarinic Medication and Accidental Bowel Leakage (BAMA)

Fecal Incontinence | Urinary Incontinence, Urge

United States
Novartis

Completed

A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.

Overactive Bladder Syndrome

United States
Lawson Health Research Institute
Brain Canada

Not yet recruiting

M3-JIA: Making Mindfulness Matter for Children With JIA (M3-JIA)

Children | Mental Health | Juvenile Idiopathic Arthritis | Mental Well-being

Canada
Wake Forest University Health Sciences

Not yet recruiting

Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct

Contracted Bladder

United States
Novartis

Completed

A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder

Overactive Bladder Syndrome

United States
University Hospital Ostrava

Recruiting

Objective Evaluation of the Effect of Oculoplastic Operations Using the Vectra M 3D Imaging System

Eyelid Ptoses | Ectropion Eyelids | Entropion;Eye

Czechia
Novartis
Procter and Gamble

Completed

Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder

Overactive Bladder

United States
Edwards Lifesciences

Active, not recruiting

SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation (SAPIEN M3 EFS)

Mitral Regurgitation | Mitral Disease

United States, Canada
Scripps Health

Completed

SmartScope vs Standard Colposcope for the Evaluation of Cervical Dysplasia

Cervical Cancer

United States
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

Overactive Bladder
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

Overactive Bladder
Chinese University of Hong Kong

Recruiting

Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA) (M3-AA)

Colorectal Adenoma | Colorectal Polyp | Advanced Adenoma

Hong Kong
Dr. Gaines W. Hammond Jr. MD FACS

Unknown

A Prospective Evaluation of the Catheter Science M3 "Mini Catheter" for Patients With Prostatic

Urinary Retention

United States
Jeil Pharmaceutical Co., Ltd.

Completed

The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.

Overactive Bladder | Benign Prostatic Hyperplasia | LUTS(Lower Urinary Tract Symptoms)
Pamukkale University

Not yet recruiting

Transcutaneous Tibial Nerve Stimulation in Antimuscarinic Naive and Refractory Women With Idiopathic Overactive Bladder

Urinary Bladder, Overactive

Turkey
Meir Medical Center

Withdrawn

Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents

Overactive Bladder
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin

Overactive Bladder | Benign Prostatic Hyperplasia | LUTS

Korea, Republic of
AstraZeneca

Completed

Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Czech Republic, Germany, Hungary, Poland
Ono Pharmaceutical Co. Ltd
Kyorin Pharmaceutical Co.,Ltd

Completed

Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder

Overactive Bladder

Japan
Centre Hospitalier Universitaire Dijon

Completed

Impact of Sports-related Concussions on the Attention and Executive Skills of Adolescents and Young Adults: Links With Subjective Symptoms and Recovery (EXAECOS)

Sports-related Concussion

France
National Taiwan University Hospital

Unknown

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug

Overactive Bladder Syndrome

Taiwan
St George Hospital, Australia

Completed

Clean Intermittant Self Catheterisation: A Trial Comparing Single Use vs Reuse of Nelaton Catheters (SURE)

Urinary Retention

Australia
AstraZeneca

Completed

Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

Germany
Far Eastern Memorial Hospital

Completed

Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing

Overactive Bladder Syndrome

Taiwan
Edwards Lifesciences

Recruiting

The ENCIRCLE Trial (ENCIRCLE)

Mitral Regurgitation | Mitral Valve Insufficiency

United States, Netherlands, Israel, Australia, Canada, United Kingdom
Mutah University

Completed

Arabic Translation and Validation of the (Overactive Bladder Symptom Score) OABSS

Overactive Bladder

Jordan
Ahram Canadian University

Completed

Post-instrumentation Pain After Use of the Fanta and M3 Pro Gold Systems

Endodontic Treatment

Egypt
Integra LifeSciences Corporation

Terminated

The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series

Pilonidal Disease

United States
National Center for Complementary and Integrative...
Office of Dietary Supplements (ODS)

Unknown

Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs)

Urinary Tract Infection

Canada
AstraZeneca

Completed

Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Spain, United Kingdom
Cairo University

Recruiting

The Efficacy of a Temporary Sub-Placental Uterine Tourniquet in Minimizing Intraoperative Blood Loss in Management of Placenta Accreta Spectrum Disorder by a Retrograde Cesarean Hysterectomy (Bladder Last)

Placenta Accreta

Egypt
Lawson Health Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

Making Mindfulness Matter© in Children With Epilepsy (M3Epilepsy)

Quality of Life | Mindfulness | Epilepsy in Children

Canada
Medical University of Warsaw

Unknown

Expression of MCM5 in Urine in Patients With Urothelial Cancers

Bladder Cancer

Poland
Solace Therapeutics, Inc.

Completed

Solace Stress Urinary inContinence Control Efficacy and Safety Study (SUCCESS)

Stress Urinary Incontinence

United States
Novartis

Completed

Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States, Spain, Turkey, France, Netherlands, Germany
University of Pittsburgh

Completed

Patient Satisfaction Study: Clean Intermittent Self-Catheterization Teaching

Anxiety

United States
University of Saskatchewan
Royal University Hospital Foundation

Completed

Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness

Asthma

Canada
Ankara Training and Research Hospital
Ministry of Health, Turkey

Completed

Behavioural Therapy With Checklist for Overactive Bladder

Overactive Bladder

Turkey
Washington University School of Medicine
American Academy of Clinical Toxicology

Not yet recruiting

Rivastigmine for Antimuscarinic Delirium (RIVA-AM)

Anticholinergic Toxicity

United States
Pfizer

Completed

A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder. (SOFIA)

Urinary Bladder, Overactive

Portugal, Spain, Turkey, Finland, Germany, Norway, Sweden, Slovakia, Italy, Austria, United Kingdom, Belgium, Denmark, Israel, Switzerland
Mansoura University

Completed

Role of Novel Urinary Genomic and Metablomic Markers in Diagnosis of Bladder Cancer in Patients With Hematuria

Bladder Cancer | Hematuria

Egypt
M3 Health
Irmandade da Santa Casa de Misericordia de Sao Paulo

Not yet recruiting

Evaluation of Plenum® Tissue Ortho to Prevent Epidural Fibrosis and Post-laminectomy Syndrome.

Herniated Disk Lumbar

Brazil
University of Oxford

Completed

A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines

HIV

United Kingdom
University of Colorado, Denver
American Academy of Clinical Toxicology

Completed

Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome (TAAT)

Anticholinergics Toxicity

United States
Philadelphia Urosurgical Associates
Drexel University College of Medicine

Unknown

A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome

Cystitis, Interstitial | Painful Bladder Syndrome

United States
Oregon Health and Science University

Completed

A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis (M3)

Psychotic Disorders | Schizophrenia

United States
Chinese University of Hong Kong
National Taiwan University Hospital; Changi General Hospital; Oxford University... and other collaborators

Recruiting

Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) for Colorectal Advanced Neoplasia (M3-PRO)

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma

Hong Kong

3

Subscribe